142 related articles for article (PubMed ID: 3132861)
1. Comparison of fibrinolytic activities of human and bovine endothelial cells.
Bartha K; Wojta J; Wagner OF; Binder BR
Am J Physiol; 1988 Jun; 254(6 Pt 2):R885-90. PubMed ID: 3132861
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals.
Shatos MA; Doherty JM; Orfeo T; Hoak JC; Collen D; Stump DC
J Biol Chem; 1992 Jan; 267(1):597-601. PubMed ID: 1730619
[TBL] [Abstract][Full Text] [Related]
3. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
Gelehrter TD; Sznycer-Laszuk R
J Clin Invest; 1986 Jan; 77(1):165-9. PubMed ID: 2418059
[TBL] [Abstract][Full Text] [Related]
4. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Konkle BA; Ginsburg D
J Clin Invest; 1988 Aug; 82(2):579-85. PubMed ID: 3136192
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
6. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelium cells can influence endothelial cell plasminogen activators.
Moisseiev J; Jerdan JA; Dyer K; Maglione A; Glaser BM
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1070-8. PubMed ID: 2354910
[TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear leukocytes regulate the plasminogen-activating system of cultured endothelial cells.
Gilboa N; Neumann PH; Del Vecchio PJ; Gudewicz PW
Biochem Int; 1988 Sep; 17(3):585-92. PubMed ID: 3264500
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.
Maiello M; Boeri D; Podesta F; Cagliero E; Vichi M; Odetti P; Adezati L; Lorenzi M
Diabetes; 1992 Aug; 41(8):1009-15. PubMed ID: 1628760
[TBL] [Abstract][Full Text] [Related]
10. Production of proteases type plasminogen activator and their inhibitor in cornea.
Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
Laug WE
Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
[TBL] [Abstract][Full Text] [Related]
13. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
van Hinsbergh VW; Bertina RM; van Wijngaarden A; van Tilburg NH; Emeis JJ; Haverkate F
Blood; 1985 Feb; 65(2):444-51. PubMed ID: 3917696
[TBL] [Abstract][Full Text] [Related]
15. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
16. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Levin EG; Santell L
J Cell Biol; 1987 Dec; 105(6 Pt 1):2543-9. PubMed ID: 3121634
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells.
Arnman V; Stemme S; Rymo L; Risberg B
Thromb Res; 1995 Mar; 77(5):431-40. PubMed ID: 7778058
[TBL] [Abstract][Full Text] [Related]
18. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
19. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
